Clinical Study On The Treatment Of Female Pelvic Organ Prolapse With Pessary

Research objective:To study the changes of relevant clinical symptoms and the effect of pessary on patients with pelvic organ prolapse(POP)after treatment,and evaluate the clinical application value of commonly used types of uterine supports in the treatment of pelvic organ prolapse patients.Research object and method:Pop patients who were treated in the gynecological clinic of Shandong provincial hospital from January 2020 to may 2021 were selected.According to the relevant inclusion and exclusion criteria,pop patients who tried to wear uterine care and successfully wore uterine care were selected as the research objects.Before wearing,they filled in the pelvic floor dysfunction inventory short form 20(pfdi-20)and self rating Anxiety Scale(SAS).After wearing uterine care for 3 months,Through telephone follow-up or hospital follow-up,fill in the pfdi-20 questionnaire and selfrating Anxiety Scale(SAS)again to obtain the changes of patients before and after wearing the uterine support,and obtain the specific score.Use SPSS 22.0 statistical software to statistically analyze the data by using the rank sum test and chi square test of paired data,so as to explore the therapeutic effect of the uterine support on the clinical symptoms and the change of psychological state of pop patients.Research results:1.A total of 175 pop patients tried to wear the uterine support,and the number of successful attempts was 118.After 3 months of follow-up,it was found that 2 cases gave up using the uterine support due to difficulties in taking and wearing,and 1 case lost follow-up.After 3 months of statistics,the number of successful wearing was 115.Therefore,the success rate of 175 pop patients wearing the uterine support for 3 months was 65.71%.The wearing age range is 22-99 years old,with an average age of 63.45 ± 11.71 years..The age range with the highest number of successful cases of wearing is between 60 and 69 years old.2.The proportion of successful trial wearing of ring(with diaphragm)and horn type uterine support:among 115 people,23.48%were wearing ring uterine support and 76.52%were wearing horn type uterine support.3.The patients were followed up after wearing the uterine support for 3 months and filled in the pelvic floor dysfunction questionnaire PDFI-20.Compared with the questionnaire score before wearing,the total score of pop patients after wearing decreased from 60.31 ± 23.62 to 13.59±5.34,and it has significantly different in some demographic variables(P<0.05).PFDI-20 consists of three parts of the questionnaire,with different changes in each part.The score of organ prolapse disease Inventory-6(POPDI-6)decreased from 22.30 ± 3.18 to 3.41 ± 1.73,and it has significantly different in some demographic variables(P<0.05);The score of colorectal symptoms inventory-8(CRADI-8)changed from 5.58 ± 4.83 to 4.91 ± 3.97,and there was no significant difference(P>0.05);The score of urinary disease inventory 6(UDI-6)decreased from 33.71 ± 15.79 to 5.82 ± 2.45(P<0.05).4.The patients were followed up after wearing the uterine care for 3 months,and the scores of self rating Anxiety Scale(SAS)filled in before and after wearing the uterine care were statistically analyzed.It was found that the number of anxiety decreased from 56 before wearing the uterine care to 13 after wearing the uterine care,and it has significantly different in some demographic variables(P<0.05).The SAS score decreased from 64.73±8.41 to 40.12 ± 7.23(P<0.05).5.Complications related problems:there were 19 patients with increased vaginal secretions,which were relieved after cleaning and proestrol administration.There was a small amount of intermittent vaginal bleeding in one case.Physical examination found a small polyp at the cervix,and the vaginal bleeding disappeared after resection.Conclusion:The pessary can improve organ prolapse and clinical symptoms of urinary system of POP patients,improve psychological anxiety and quality of life.The short-term wear complications is easy to deal with.The pessary has positive significance for the treatment of POP patients.